# Glenmark Pharmaceuticals Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e

> Inspection records and compliance data for Glenmark Pharmaceuticals Limited in Colvale, None. Access full analysis and detailed observations.

---

## Details

- Name: Glenmark Pharmaceuticals Limited
- FEI Number: 3004672766
- City: Colvale
- State: None
- Country Name: India
- Address Line 1: Plot No S - 7, Colvale Industrial Estate
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-limited/057fe8cd-6838-4327-af2d-357c2360ff67) — source: FDA, date: May 20, 2022
- [483 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-limited/093337ff-63f2-4cf2-8f60-4218782af640) — source: FDA, date: May 20, 2022
- [FDA Inspection 1170118 - Glenmark Pharmaceuticals Limited - 2022-05-20](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-limited/3db03adb-b93f-4e9a-8ec6-4f05144e5a4f) — classification: Official Action Indicated (OAI), source: FDA, date: May 20, 2022
- [483 - Glenmark Pharmaceuticals Limited - 2019-09-27](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-limited/1b6b5a08-12ee-4621-95d3-64968e415cc1) — source: FDA, date: September 27, 2019
- [483 - Glenmark Pharmaceuticals Limited - 2019-03-15](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-limited/61572250-35a3-4c58-8beb-ef4ed0be77a2) — source: FDA, date: March 15, 2019
- [FDA Inspection 1082656 - Glenmark Pharmaceuticals Limited - 2019-03-15](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-limited/76994ec3-3b82-446f-9cf1-7c06892b1e58) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2019
- [FDA Inspection 885332 - Glenmark Pharmaceuticals Limited - 2014-05-30](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-limited/94186246-e235-4bad-87ed-848e5becfc54) — classification: No Action Indicated (NAI), source: FDA, date: May 30, 2014
- [FDA Inspection 849889 - Glenmark Pharmaceuticals Limited - 2013-07-19](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-limited/d3bf1a09-8a2e-4b48-a074-e7143a83a5d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2013
- [FDA Inspection 752519 - Glenmark Pharmaceuticals Limited - 2011-10-12](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-limited/ffeb2946-9761-4490-b5c7-658b5d38daaa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 12, 2011
- [FDA Inspection 628368 - Glenmark Pharmaceuticals Limited - 2009-11-20](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-limited/9ba33da9-06fd-42b3-b46a-eebadb627bbf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2009

## Related Companies

- [Charles River Laboratories Inc](https://www.globalkeysolutions.net/companies/charles-river-laboratories-inc/876b68d9-6285-4039-8732-05f876b5d911)
- [Seqirus Inc](https://www.globalkeysolutions.net/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [Nephron Sc Inc](https://www.globalkeysolutions.net/companies/nephron-sc-inc/2dadfd52-37b7-4da6-9885-864d470c1b18)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.globalkeysolutions.net/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Oxalis Labs](https://www.globalkeysolutions.net/companies/oxalis-labs/bc19741c-c2c0-43bc-80ad-91eda4acf921)
- [Mylan Laboratories Limited](https://www.globalkeysolutions.net/companies/mylan-laboratories-limited/b7da9cbd-d5e3-417f-a485-f9e38852b256)
- [Oishi Koseido Co., Ltd.](https://www.globalkeysolutions.net/companies/oishi-koseido-co-ltd/07ae7f38-2728-4248-8ef1-ff0abd9a79e7)
- [TOLMAR, Inc.](https://www.globalkeysolutions.net/companies/tolmar-inc/a73dea00-baea-4f0e-8234-c0becc61322e)
- [Laboratorio Reig Jofre S.A.](https://www.globalkeysolutions.net/companies/laboratorio-reig-jofre-sa/a6b83a70-2bd5-4cc1-8007-61357916a14f)
- [Oxford Pharmaceuticals, LLC](https://www.globalkeysolutions.net/companies/oxford-pharmaceuticals-llc/5294310a-05a2-4599-bf9e-720929f040ee)

## Related Officers

- [Sandra A. Hughes](https://www.globalkeysolutions.net/people/sandra-a-hughes/ee1b9542-fe28-4618-a666-67a1ff736481)
- [Michele L. Glendenning](https://www.globalkeysolutions.net/people/michele-l-glendenning/a3c23a43-634c-4140-807b-c17fbc03bb00)
- [Jose M. Cayuela](https://www.globalkeysolutions.net/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)